Cresilon, Inc.
through Jun 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Apr 29, 2026 · D | Jun 26, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $25,000,000 | $29,000,000 | $4,000,000 |
| Reported amount sold | $4,997,000 | $28,999,199 | $24,002,199 |
| Reported investor count | — | 217 | — |
| Reported minimum investment | $12,000 | $10,000 | $-2,000 |
Earlier SEC source: 0001728054-26-000001 · Later SEC source: 0001728054-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $29,000,000
- Reported amount sold
- $28,999,199
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20253 filings
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (5)
-
0001728054-26-000002D/A · Jun 26, 2026 · BiotechnologyOffering: $29,000,000Sold: $28,999,199
-
0001728054-26-000001D · Apr 29, 2026 · BiotechnologyOffering: $25,000,000Sold: $4,997,000
-
0001728054-25-000004D · Dec 8, 2025 · BiotechnologyOffering: $6,716,808Sold: $6,683,401
-
0001728054-25-000003D · Sep 5, 2025 · BiotechnologyOffering: $34,797,261Sold: $17,172,969
-
0001728054-25-000001D · Jan 31, 2025 · BiotechnologyOffering: $25,000,000Sold: $24,999,967